Amneal Pharmaceuticals, Inc. (AMRX) Social Stream
Amneal Pharmaceuticals Inc (AMRX) Price Targets From Analysts
Use the tables below to see what analysts covering Amneal Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
AMRX's average price target has moved up $2.1 over the prior 20 months.
Over the past 139 days, AMRX's average upside potential has been 38.87%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
AMRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
AMRX's average broker recommendation rating worsened by 0.27 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMRX as an investment opportunity.
- In the context of all US stocks, Amneal Pharmaceuticals Inc's average analyst price target is greater than 14.16% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Amneal Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 67.76% of them.
- AMRX has a lower variance in analysts' estimates than -15.4% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, Amneal Pharmaceuticals Inc's number of analysts covering the stock is greater than 156.8% of them.
In the Pharmaceutical Products industry, AMRN, ALXO, and ALLK are the three stocks most similar to Amneal Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is AMRX a Buy, Hold or Sell? See the POWR Ratings now!